XML 13 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues:    
Product sales and services $ 35,353 $ 32,726
License and research revenue 863 0
Total 36,216 32,726
Operating expenses:    
Cost of products and services sold 4,395 3,630
Research and development expenses 5,388 6,022
Selling, general and administrative expenses 9,461 4,463
Intangible asset amortization 3,514 3,143
Changes in fair value of related party acquisition-related contingent consideration 7,916 5,254
Total 30,674 22,512
Operating income 5,542 10,214
Investment Income 200 664
Interest Expense (175) 0
Interest Expense - changes in fair value of related party financing-relatedcontingent consideration (1,861) (259)
Foreign exchange gain (loss) (2,941) 11,501
Income before income taxes 765 22,120
Income tax provision 7,141 10,473
Net income (loss) $ (6,376) $ 11,647
Earnings (loss) per share - Basic:    
Net income (loss) per share - Basic (in dollars per share) $ (0.15) $ 0.29
Earnings (loss) per share - Diluted:    
Net income (loss) per share - Diluted (in dollars per share) $ (0.15) $ 0.27
Earnings (loss) per share    
Weighted average number of shares outstanding - Basic (in shares) 41,241 40,207
Weighted average number of shares outstanding - Diluted (in shares) 41,241 42,879